Structures by: Freeman S.
Total: 18
C12H20Ba3O22,4(H2O)
C12H20Ba3O22,4(H2O)
Faraday discussions (2015) 179, 343-357
a=13.4109(2)Å b=16.2568(4)Å c=27.9028(6)Å
α=90° β=98.984(2)° γ=90°
4,6-bispyrenoyl-myo-inositol 1,2,3,5-tetrakis(dibenzyl phosphate)
C96H80O20P4
Organic & biomolecular chemistry (2010) 8, 12 2850-2858
a=15.160(2)Å b=15.211(2)Å c=19.507(2)Å
α=69.540(2)° β=83.666(2)° γ=77.071(2)°
C39H49Cl3N5OTi
C39H49Cl3N5OTi
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.8984(8)Å b=18.7455(11)Å c=18.6503(14)Å
α=90.00° β=93.343(3)° γ=90.00°
C39H49Cl2N5OV,2(C4H8O)
C39H49Cl2N5OV,2(C4H8O)
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.306(3)Å b=32.019(11)Å c=13.807(5)Å
α=90.00° β=90.00° γ=90.00°
C39H49Br2N5OV
C39H49Br2N5OV
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=15.6919(15)Å b=14.6332(15)Å c=17.1157(12)Å
α=90° β=102.828(7)° γ=90°
C35H41Cl3N5V,C4H8O
C35H41Cl3N5V,C4H8O
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.8934(12)Å b=18.7259(17)Å c=18.381(2)Å
α=90.00° β=94.051(8)° γ=90.00°
C82H106Br4Cl0Cr2N10O3
C82H106Br4Cl0Cr2N10O3
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=34.5630(7)Å b=34.5630(7)Å c=41.0813(15)Å
α=90.00° β=90.00° γ=120.00°
C35H41Br2Mn,C4H8O
C35H41Br2Mn,C4H8O
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.6948(8)Å b=18.7188(14)Å c=19.2039(19)Å
α=90.00° β=93.796(9)° γ=90.00°
C35H41Cl3N5Nb,C4H8O
C35H41Cl3N5Nb,C4H8O
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.803(7)Å b=18.707(11)Å c=18.838(17)Å
α=90.00° β=92.61(6)° γ=90.00°
C35H41Cl4N5U,C4H8O
C35H41Cl4N5U,C4H8O
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.7146(8)Å b=18.384(2)Å c=20.229(4)Å
α=90.00° β=93.628(10)° γ=90.00°
C39H49Cl2N6Ti
C39H49Cl2N6Ti
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=10.802(9)Å b=13.630(13)Å c=32.45(2)Å
α=90.00° β=90.00° γ=90.00°
C39H47B2F8N7OV(C2H3N)
C39H47B2F8N7OV(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=16.851(3)Å b=12.707(4)Å c=21.564(4)Å
α=90.00° β=100.152(13)° γ=90.00°
C35H41Cl2N5OV
C35H41Cl2N5OV
Dalton transactions (Cambridge, England : 2003) (2006) 6 775-782
a=16.699(5)Å b=19.125(5)Å c=22.226(6)Å
α=90.00° β=97.012(4)° γ=90.00°
C47H40O8Si,CHCl3
C47H40O8Si,CHCl3
Chemical communications (Cambridge, England) (2008) 41 5161-5163
a=11.1679(9)Å b=11.6838(9)Å c=16.9249(13)Å
α=72.420(2)° β=81.387(2)° γ=87.634(2)°
C30H32N4O6S2
C30H32N4O6S2
Chem.Commun. (2012) 48, 6393
a=24.0493(16)Å b=21.2442(13)Å c=11.3248(5)Å
α=90.00° β=90.00° γ=90.00°
(+/-)-cis-1,2-O-Cyclohexylidene-3,4,5,6-tetra-O-benzyl myo-inositol
C40H44O6
Acta Crystallographica Section C (1996) 52, 10 2575-2578
a=10.608(3)Å b=19.147(6)Å c=17.448(5)Å
α=90.00° β=107.22(2)° γ=90.00°
6-Nitrophthalide
C8H5NO4
Acta Crystallographica Section C (1997) 53, 11 1626-1628
a=9.2511(10)Å b=13.513(3)Å c=6.1542(3)Å
α=90.00° β=90.00° γ=90.00°
Phosphinoalanine monohydrate, 2-amino-3-phosphinopropanoic acid monohydrate
C3H8NO4P,H2O
Acta Crystallographica Section C (1993) 49, 10 1826-1828
a=6.669(2)Å b=14.8420(10)Å c=7.7000(10)Å
α=90° β=96.580(10)° γ=90°